CAAP Company: CellAegis Devices Announces US$9.5 Million Financing

Ontario Industry Updates
Written By obio

Former OBIO CAAP company CellAegis Devices, has announced $9.5 Million US financing to support clinical and regulatory advancement of their autoRIC® Device.

This device automatically delivers Remote Ischemic Conditioning (RIC) to provide a non-invasive, cardio-protective therapy shown to reduce heart damage during heart attacks and other cardiovascular procedures.

Read the full Press Release HERE

obio
Previous

CAAP Company: Eve Medical

Next

CAAP Company: Conavi Medical Announces Health Canada Approval